Christine Dolan - 29 Apr 2022 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Operating Officer, Biologics Safety Testing
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Issuer symbol
MRVI
Transactions as of
29 Apr 2022
Net transactions value
+$15,285
Form type
4
Filing time
27 Jun 2022, 18:42:46 UTC
Previous filing
27 Jan 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $15,285 +666 +3.7% $22.95 18,785 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 666 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Chief Operating Officer, Biologics Safety Testing